Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
An expert panel reviewing two network meta-analyses found favorable efficacy rankings for adjunctive lumateperone in major depression, alongside higher discontinuation risks. The indirect comparisons do not establish superiority over other agents.
Family Medicine/General Practice November 10th 2026
Verywell Health
A consumer overview describes metformin’s potential roles in weight management, ovarian syndrome symptoms, and cardiovascular outcomes, but the reported findings involve different populations and do not establish equivalent benefits across these uses.
Clinical Pharmacology November 3rd 2026
Specialty Pharmacy Continuum
Accreditors described new programs for artificial intelligence and immunoglobulin services, revised oncology dispensing materials, and more frequent DMEPOS surveys, with differing eligibility, payer recognition, and compliance implications across specialty pharmacy settings.
Pharmacy Practice News
Conference presenters highlighted gaps in menopause medication coverage and follow-up support, describing opportunities for pharmacist involvement while offering no comparative evidence that employer-sponsored programs improve symptoms, adherence, or workplace outcomes.
Clinical Infectious Diseases (CID)
Updated infectious diseases guidance addresses resistant gram-negative infections through pathogen-specific treatment pathways, incorporating newer antibiotics and pharmacologic considerations while acknowledging that several preferred approaches rest on limited clinical outcomes data.
Medical Xpress
Researchers reported changes in brain functional connectivity after adding N-acetylcysteine to ongoing multiple sclerosis treatment, an early imaging signal that requires confirmation in larger studies with defined dosing and clinical outcomes.